Nyumbani › Sarcoma ya Neuroendocrine
Majaribio ya kliniki ya Sarcoma ya Neuroendocrine yanayovutia washiriki nchini Marekani
Masomo 16 ya Sarcoma ya Neuroendocrine yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Houston, TXUtafiti 6
- New York City, NYUtafiti 6
- Arlington, VAUtafiti 5
- Los Angeles, CAUtafiti 4
- Dallas, TXUtafiti 4
- Washington, DCUtafiti 4
- Seattle, WAUtafiti 3
- Columbus, OHUtafiti 3
- Atlanta, GAUtafiti 3
- New Haven, CTUtafiti 3
- Grand Rapids, MIUtafiti 3
- Nashville, TNUtafiti 3
- Denver, COUtafiti 3
- St. Louis, MOUtafiti 3
Kwa jimbo
- CaliforniaUtafiti 6
- ColoradoUtafiti 4
- ConnecticutUtafiti 3
- FloridaUtafiti 5
- GeorgiaUtafiti 4
- LouisianaUtafiti 3
- MarylandUtafiti 6
- MichiganUtafiti 3
- MissouriUtafiti 3
- New JerseyUtafiti 4
- New YorkUtafiti 6
- OhioUtafiti 4
- TennesseeUtafiti 4
- TexasUtafiti 8
- VirginiaUtafiti 5
- WashingtonUtafiti 4
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
InaajiriHatua 2
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06406465Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
InaajiriHatua 1
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07509034Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
InaajiriUtafiti wa uchunguzi
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT05237934Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07278479Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07080242A Study of Armored CAR T Cells in People With Cancer
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT07783477A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 25 Ago 2026 · NCT07488923A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 5 Ago 2026 · NCT06330064A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 31 Jul 2026 · NCT07129252A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 15 Jul 2026 · NCT05652686Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
InaajiriHatua 1/2
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 13 Jul 2026 · NCT05000294A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Jul 2026 · NCT07174583A First-in-Human Phase I Trial With Antibody Drug Conjugate ADCT-701 in Neuroendocrine Tumors, Carcinomas and Malignant Peripheral Nerve Sheath Tumors
InaajiriHatua 1
Umri 18 hadi 120 · Jinsia zote · Imesasishwa 15 Jun 2026 · NCT06041516A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
InaajiriHatua 1/2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 27 Mei 2026 · NCT03093116SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Differentiated High-Grade Neuroendocrine Tumors (NET)
InaajiriHatua 1
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Apr 2026 · NCT06889493A Study of MT-4561 in Patients With Various Advanced Solid Tumors
InaajiriHatua 1/2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 11 Des 2025 · NCT06943521Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.